Earnings ·
Chemed reports Q3 diluted EPS of $5.45 and revenue of $690.9 million
CHEChemed Corp
Chemed Corporation reported third-quarter results ending September 30, 2026, with consolidated revenue increasing 10.6% to $690.9 million. GAAP diluted earnings per share rose 22.2% to $5.45, while adjusted diluted EPS increased 28.1% to $6.75. The VITAS hospice segment drove growth with net patient revenue up 12.2% to $457.4 million and average daily census rising 9.4%. Roto-Rooter plumbing services saw revenue grow 7.5% to $233.5 million, though adjusted EBITDA declined slightly by 2.5%. The company also repurchased 125,000 shares for $66.0 million and updated full-year guidance to be at or above the high-end of previous estimates. Chemed operates in the healthcare field through its VITAS Healthcare Corporation subsidiary providing end-of-life care, and in the residential and commercial plumbing industry under the Roto-Rooter brand.